Global drugmakers eye more China biotech deals after record year (asia.nikkei.com)
from schizoidman@lemmy.zip to world@lemmy.world on 30 Apr 11:49
https://lemmy.zip/post/63480005

no paywall

2025 was a breakout year for China’s biopharma industry. Out-licensing deals, in which a Chinese biotech company grants another drugmaker the rights to develop, produce and sell its drug candidates, hit a record $135.7 billion, according to data provider Pharmcube. That was nearly triple the value in 2024.

#world